Juliet Tammenoms Bakker, Director at RxSight, Inc. (RXST), sold 1,434,026 shares at $29.77 ($29.4M) on 2023-11-29, disclosed to the SEC on 2023-11-30.
Open-market sale of $29.4M RXST by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.62 | 145,068 | $4.3M | 14.6% |
| 2 | $29.62 | 145,068 | $4.3M | 14.6% |
| 3 | $29.77 | 349,245 | $10.4M | 35.4% |
| 4 | $29.77 | 349,245 | $10.4M | 35.4% |
| 5 | $0.00 | 445,400 | $0 | 0.0% |
| Total | $20.49 avg | 1,434,026 |
| $29.4M |
| 100% |
| Filing → |
| RXST | BUY | 2024-02-15 | $407K | — | Filing → |
| RXST | SELL | 2023-11-16 | $13.6M | — | Filing → |
| RXST | SELL | 2023-09-11 | $2.0M | — | Filing → |